Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 97 for your search:
Cancer Type/Condition:  rectal cancer, colon cancer
Trial Type:  Screening, Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 58 to 60
Sponsor: Other
Protocol IDs: 14334-c27.2, NCT01739608

2.

Phase: Phase IV
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1, NCT02032914

3.

Phase: Phase IV
Type: Diagnostic, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 6011440, DMED-1658-13, NCT02065037

4.

Phase: Phase III, Phase II
Type: Screening
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 190-CLD-AOS, NCT00867724

5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: S10251, NCT01426490

6.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688

7.

Phase: Phase III
Type: Screening
Status: Active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792

8.

Phase: Phase III
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000654114, FFCD-PRODIGE-13, 2009-A00536-51, EU-20979, PRODIGE 13, FFCD 0902, NCT00995202

9.

Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881

10.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2011.125-T, NCT01434199

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPP-FAP-310, NCT01483144

12.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409

14.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-01/2014 (NOCT), 29672, NCT02254486

15.

Phase: Phase III
Type: Health services research, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 102014, NCT02272036

16.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-03/2014 (DAYB), NCT02273141

17.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-02/2014 (MORA), NCT02273167

18.

Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325

19.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641

20.

Phase: Phase II
Type: Prevention
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 23266, KUN 2003-2911, NCT00319007

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: MIRACLE, NCT01360320

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

24.

Phase: Phase II
Type: Screening
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CD-1158, NCT01549535

25.

Phase: Phase II
Type: Screening
Status: Active
Age: 50 to 74
Sponsor: NCI, Other
Protocol IDs: UH3CA188640, 1UH2AT007782-01, NCT01742065
1     
New Search